Entity
Description
  • Value proposition

    Foundation models for RNA-centric drug discovery

    At Atomic AI, we build artificial intelligence to pioneer new frontiers in drug discovery. Our unique R&D platform, an early version of which was featured on the cover of Science, enables the design of novel, RNA‐centric medicines for areas of high unmet need. We continue to advance this platform by developing new machine learning methods and unique foundation models fueled by our large-scale, in-house experimental data collection. We are an interdisciplinary team of scientists and engineers and believe our people are our greatest strength and the key to our success.

Catalyst interactions
Catalyst Type Tweets Articles
Gilead Sciences
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research (Auto)
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research (Auto)
Other

11 Jan 2026


Google
Google
IT services, Software Development (Auto)
Google
IT services, Software Development (Auto)
Other

31 Mar 2025


NYSE
NYSE
Finance, Financial Services (Auto)
NYSE
Finance, Financial Services (Auto)
Other

22 Feb 2024


CB Insights
CB Insights
Consulting, Technology, Information and Internet (Auto)
CB Insights
Consulting, Technology, Information and Internet (Auto)
Other

30 Nov 2023


Social network dynamics
Similar entities
BETA
Loading...
Loading...